Table 1:

Characteristics of patients with and without reversion of collateralsa

Reversion of CollateralsP Value
Yes (n = 25)No (n = 23)
Age (median) (IQR)78 (71–81)79 (68–86).52
Male sex (No.) (%)13 (52)13 (57).78
mRS 0–1 before stroke (No.) (%)25 (100)22 (96).48
Cardiovascular risk factors (No.) (%)
    Hypertension15 (60)13 (57)1
    Diabetes mellitus7 (28)3 (13).29
    Hyperlipidemia4 (16)7 (30).31
    Atrial fibrillation21 (84)13 (57).057
    Congestive heart failure5 (20)4 (17)1
    Previous stroke6 (24)6 (26)1
    Smoking9 (36)9 (41).77
Past medication at stroke onset (No.) (%)
    Antiplatelet therapy7 (28)8 (35).76
    Anticoagulant therapy5 (20)4 (17)1
    Antihypertensive therapy13 (52)10 (44).58
    Statin therapy2 (8)4 (17).41
Stroke etiology (No.) (%)
    Cardioembolism19 (76)11 (48).07
    Atherosclerosis4 (16)8 (35).19
    Other or undetermined2 (8)4 (17).41
Severity of stroke at arrival (median) (IQR)
    Initial GCS13 (11–14)12 (10–14).62
    Initial DWI volume (mL)21.6 (13.8–42.5)22.9 (10.6–41.1).63
    DWI ASPECTS at arrival8 (7–9)8 (6–8).72
    Initial NIHSS score17 (14–24)16 (11–21).35
Duration between 2 MRI scans (days)7 (5–9)6 (3–8).2
Neurologic and radiologic outcome after rtPA (median) (IQR)
    24-hr NIHSS7 (2–12)11 (6–17).022b
    7-day NIHSS4 (1–8)8 (3–14).008c
    Hemorrhagic transformation6 (24)10 (43).22
    Successful recanalization23 (92)8 (35)<.001d
    Follow-up CT ASPECTS8 (6.5–9)6 (4–8).017b
        M1 to M6 area in ASPECTS5 (4–6)3 (2–6).021b
        C, I, L, IC area in ASPECTS3 (2.5–4)3 (2–3).12
    mRS 0–1 at 3 mo (No.) (%)16 (64)8 (35).043b
  • Note:—GCS indicates Glasgow Coma Scale; C, caudate nucleus; I, insular cortex; L, lenticular nucleus; IL, internal capsule.

  • a For continuous variables, the median and P values (Mann-Whitney U test) are shown. The resulting proportions and the P values (Fisher exact test with Yates correction, when appropriate) are shown.

  • b P < .05.

  • c P < .01.

  • d P < .001 was considered significant.